Mirum Pharmaceuticals, Inc. (MIRM)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q2-2026 | 8-K (2026-08-05) · 99.1 | ||
| 10-Q | Q1-2026 | 8-K (2026-05-06) · 99.1 | ||
| 10-KLatest | FY-2025 | 8-K (2026-02-25) · 99.1 | 8-K (2026-01-12) · 99.1 · 99.2 | ||
| 10-Q | Q3-2025 | 8-K (2025-11-04) · 99.1 | ||
| 10-Q | Q2-2025 | 8-K (2025-08-06) · 99.1 | ||
| 10-Q | Q1-2025 | 8-K (2025-05-07) · 99.1 | ||
| 10-K | FY-2024 | 8-K (2025-02-26) · 99.1 | 8-K (2025-01-13) · 99.1 · 99.2 | ||
| 10-Q | Q3-2024 | 8-K (2024-11-12) · 99.1 | ||
| 10-Q | Q2-2024 | 8-K (2024-08-07) · 99.1 | ||
| 10-Q | Q1-2024 | 8-K (2024-05-08) · 99.1 | ||
| 10-K | FY-2023 | 8-K (2024-02-28) | 8-K (2024-01-08) · 99.1 · 99.2 | ||
| 10-Q | Q3-2023 | 8-K (2023-11-02) · 99.1 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Cover | ||
| Document and Entity Information | ||
| Audit Information | — |
|
| Statements | ||
| Consolidated Balance Sheets | ||
| Consolidated Balance Sheets (P) | ||
| Consolidated Statements of Operations | ||
| Condensed Consolidated Statements of Comprehensive Income (loss) (unaudited) | — |
|
| Consolidated Statements of Comprehensive Loss | ||
| Condensed Consolidated Statements of Stockholders' (deficit) Equity (unaudited) | — |
|
| Consolidated Statements of Stockholders' Equity | ||
| Condensed Consolidated Statements of Stockholders' (deficit) Equity (unaudited) (P) | — |
|
| Consolidated Statements of Stockholders' Equity (P) | ||
| Consolidated Statements of Cash Flows | ||
| Condensed Consolidated Statements of Cash Flows (unaudited) (P) | — |
|
| Notes | ||
| Asset Acquisitions | ||
| Balance Sheet Components | ||
| Collaboration and License Agreements | ||
| Commitments and Contingencies | ||
| Contingencies | — |
|
| Convertible Notes | ||
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Fair Value Measurements | ||
| Financial Instruments | ||
| Gain From Sale of Priority Review Voucher | — |
|
| Income Taxes | — |
|
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| Leases | ||
| License Agreements | — |
|
| Organization and Description of Business | ||
| Pay Vs Performance Disclosure | ||
| Revenue Interest Purchase Agreement | ||
| Segment Reporting | ||
| Stock-based Compensation | ||
| Stockholders' Equity | ||
| Subsequent Events | ||
| Summary of Significant Accounting Policies | ||